NAFDAC  raises alarm over fake cholera vaccine in circulation 


The National Agency for Food and Drug Administration and Control (NAFDAC) has warned  the general public especially health care providers on the existence of fake Dukoral Oral Cholera vaccine circulating in Bangladesh.

The Director-General of NAFDAC, Prof. Moji Adeyeye  disclosed this in a statement  issued in Abuja.

She said that the packaging of the falsified Dukoral vaccine displays texts in English and French language.

Adeyeye also said efforts were  being made to raise the awareness of health care providers and the society at large.

She also said that the World Health Organization(WHO) have quarantined the 8,000 falsified packs of the said drug.

‘The World Health Organisation (WHO) had quarantined some quantities of the falsified vaccine’’.

 “The details of the falsified Dukoral Oral Cholera vaccines identified in Bangladesh are as follows – Product Name Dukoral Oral Cholera Vaccine/ Vaccin Oral contre le Cholera Batch Number KV8262B1 Expiry Date 2020-04 Stated Manufacturer Valneva Canada Inc.

“Note that the logo of the manufacturer Crucell is also displayed,” the NAFDAC DG explained.

She further clarified that the manufacturer of genuine Dukoral Oral Cholera Vaccine was Valneva Sweden AB, formerly Crucell Sweden AB.

“Valneva Sweden AB, the manufacturer of genuine Dukoral Oral Cholera vaccine stated that the combination of the manufacturers, Valneva Canada Inc and Crucell should not exist on any packaging of the vaccine in the market. “Dukoral Oral Cholera vaccine manufactured by Valneva Canada Inc is not registered by NAFDAC.

Adeyeye warned all importers, wholesalers and retailers to desist from illegal importation, distribution and sale of the falsified vaccine.

Read also: PDP candidate rejects election result, heads to tribunal

Adeyeye added that NAFDAC has strengthened all surveillance at all ports of entry so as to prevent illegal importation of the falsified Dukoral Oral Cholera vaccine from Bangladesh.

 “NAFDAC has also heightened surveillance to prevent distribution and sale of the falsified vaccine.

“Health care providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified Dukoral vaccine.

“Anybody in possession of the falsified vaccine should submit it to the nearest NAFDAC office,” she advised.

Adeyeye further urged consumers to report any harmful event related to the use of vaccines to the nearest NAFDAC office via – NAFDAC PRASCOR 20543 (toll free from all Network ) or via


Comments are closed.